Consolidated Balance Sheets - USD ($)	Dec. 31, 2018	Dec. 31, 2017
Current assets
Cash and cash equivalents	$ 68,513	$ 10,158
Receivables	14,516	2,849
Total current assets	83,029	13,007
Software		45,229
Investment in equity method investee	450,683	452,336
Total assets	533,712	510,572
Current liabilities
Accounts payable and accrued liabilities	225,430	480,719
Due to related parties	11,750	11,750
Convertible notes payable, net of discount	20,000	172,230
Derivative liability		319,041
Total current liabilities	257,180	983,740
Total liabilities	257,180	983,740
Stockholders' Equity (Deficit)
Preferred stock, 5,933,333 shares authorized, $0.0001 par value, 4,000,000 issued and outstanding	400	400
Common stock; $0.0001 par value; 100,000,000 shares authorized; 4,456,452 and 2,435,179 shares issued and outstanding as of December 31, 2018 and 2017, respectively.	446	244
Additional paid-in capital	15,404,716	14,676,221
Accumulated deficit	(15,129,237)	(15,150,240)
Total stockholders' equity (deficit)	276,532	(473,168)
Total liabilities and stockholders' equity (deficit)	533,712	510,572
Preferred Stock - Series B Member]
Stockholders' Equity (Deficit)
Preferred stock, 5,933,333 shares authorized, $0.0001 par value, 4,000,000 issued and outstanding	7	7
Preferred Stock - Series C Member]
Stockholders' Equity (Deficit)
Preferred stock, 5,933,333 shares authorized, $0.0001 par value, 4,000,000 issued and outstanding	$ 200	$ 200